Table 1.
Blood tests in 2014, 2016 (major leak) and 2017 (follow-up)
| Normal range | 2014 | 2016 | 2017 | ||||
| October | February | ||||||
| 4th | 6th | 12th | 13th | ||||
| 08:00 | 14:00 | 06:00 | |||||
| Albumin | 3.6–4.5 g/dL | 3.6 | 3.8 | 0.8 L | 3.2 L | 2.8 L | 4 |
| Haemoglobin | 13.8-17.2 g/dL | 19.3 H | 8.3 | 25.8 H | 10.3 L | 11.9 L | 16.6 |
| EVF | 40–50% | 51 H | 39 | 56 H | 30 L | 35 L | 48 |
| Creatinine | 60–105 μmol/L | 94 | 83 | 227 H | 191 H | 259 H | 77 |
| Sodium | 137–145 mmol/L | 137 | 141 | 141 | 147 H | 144 | 140 |
| Potassium | 3.5–4.6 mmol/L | 4.6 | 4 | 3.7 | 3.2 L | 4.6 | 4.2 |
| Phosphate | 0.71–1.23 mmol/L | 4.09 H | 2.89 H | 2.59 H | |||
| ALT | 10–70 U/L | 19 | 23 | 398 H | 458 H | 380 H | 47 (June) |
| TNT | 14 ng/L | 219 H | 829 H | 827 H | |||
| Creatine kinase | 50–270 U/L | 254 H | 6266 H | ||||
| Myoglobin | <75 μg/L | 273 H | 10936 H | ||||
| CRP | <8 mg/L | 6.4 | 2.9 | 5.5 | 3.7 | 43 H | 1.4 |
| Leukocytes | *109/L | 5.7 | 3.3 | 12.9 H | 8.4 | 8.5 | 3.7 |
| Thrombocytes | *109/L | 211 | 174 | 106 L | 106 L | 98 L | 191 |
| Lactate, arterial | 0.5–2.5 mmol/L | 8.2 H | 14.8 H | 4.7 H | |||
| D-dimer | <0.5 mg/L | >20 H | >20 H | 7.0 H | |||
| INR/pp | <1.2/0.6–1.3 | /1.2 | /1.2 | 3.6 H | 1.7 H | 1.1 | |
| APTT | 25–38 s | >150 H | >134 H | 45 H | |||
| M-spike (plasma) mg/dL |
Positive
100 |
Positive (kappa IgG) 520 |
|||||
| Kappa chain | 0.33-1.94 mg/dL | 48 H | |||||
| Lambda chain | 0.57-2.63 mg/dL | 2.07 | |||||
| Ratio kappa/lambda | 0.26–1.65 | 2.31 H | |||||
| Complement C1q | 0.24–0.61 μg/mL | 0.35 | |||||
| Complement C3c | 90-180 mg/dL | 0.49 49 L | 129 (2016) | ||||
| Complement C4 | 10-40 mg/dL g/L | 0.08 8 L | 30 (2016) | ||||
| IgA | 80-490 mg/dL | 109 | 140 | ||||
| IgG | 610-1490 mg/dL | 530 L | 1600 H | ||||
ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; CRP, C reactive protein; EVF, erythrocyte volume fraction; H, high; INR, international normalized ratio; L, low; TNT, troponine T.